Melanoma is a type of cancer that originates from melanocytes, the cells responsible for producing skin pigment, and is known ...

Black Diamond Therapeutics has deprioritized one of its two clinical-stage lung cancer contenders, jettisoned two executives ...

The 48-year-old claims doctors blamed the symptoms on her going through the menopause, but after being reportedly dismissed ...

Patients with wild-type metastatic melanoma that progressed on frontline PD-1 inhibition had almost a 2-year median overall ...

Key mechanism of resistance to BRAF-targeted melanoma therapy discovered. Potential for developing new cancer therapies with high efficacy by regulating polyamine biosynthesis to suppress resistance.

Despite being a cancer counsellor, Jo Shaw Pyke, from South Shields, Tyne and Wear, had never heard of the vulvar mucosal melanoma cancer with which she was diagnosed ...

Anchor] Melanoma, a type of skin cancer, has a mortality rate of more than 70%, but anticancer drugs currently used in ...

Patients were at least 18 years of age, had an ECOG performance status of 0 (fully active) or 1 (limited activity), and known ...

Erasca has streamlined its pipeline, now focusing on a phase 3 trial for Naporafenib targeting NRAS-mutant melanoma. Read ...

Baton Rouge Head Start serves less than half the 3- and 4-year-olds it served pre-pandemic. To recover, early childhood ...

Pasithea Therapeutics today announced safety, tolerability, pharmacokinetic (PK) and preliminary efficacy data from the first 2 cohorts of patients (n=6) in its Phase 1 clinical trial of PAS-004, ...

On Thursday, Pasithea Therapeutics Corp. (NASDAQ:KTTA) announced safety, tolerability, pharmacokinetic (PK), and preliminary ...